Jose Altamirano
Overview
Explore the profile of Jose Altamirano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Wang L, Maestri E, Jacob A, Do W, Mayo S, et al.
Hepatology
. 2024 Sep;
PMID: 39325984
Background And Aims: Alcohol-associated hepatitis (AH) is associated with very high mortality despite abstinence from alcohol; up to 40% of patients die within 6 months of diagnosis. Patients with AH...
2.
Kreimeyer H, Gonzalez C, Fondevila M, Hsu C, Hartmann P, Zhang X, et al.
Gut
. 2024 Jul;
74(1):103-115.
PMID: 39033024
Objective: Patients with alcohol-associated hepatitis (AH) have a high mortality. Alcohol exacerbates liver damage by inducing gut dysbiosis, bacterial translocation and inflammation, which is characterised by increased numbers of circulating...
3.
Yamazaki T, Kouno T, Hsu C, Hartmann P, Mayo S, Zhang X, et al.
Hepatology
. 2024 Feb;
80(2):403-417.
PMID: 38377466
Background And Aims: Patients with alcohol-associated hepatitis (AH) have an altered fecal metabolome, including reduced microbiota-derived tryptophan metabolites, which function as ligands for aryl hydrocarbon receptor (AhR). The aim of...
4.
Argemi J, Latasa M, Atkinson S, Blokhin I, Massey V, Gue J, et al.
Nat Commun
. 2023 Feb;
14(1):757.
PMID: 36765087
No abstract available.
5.
Jimenez C, Ventura-Cots M, Sala M, Calafat M, Garcia-Retortillo M, Cirera I, et al.
Liver Int
. 2022 Feb;
42(5):1109-1120.
PMID: 35220659
Background & Aims: Alcoholic hepatitis (AH) is associated with a high incidence of infection and mortality. Rifaximin reduces bacterial overgrowth and translocation. We aimed to study whether the administration of...
6.
Ventura-Cots M, Argemi J, Jones P, Lackner C, Hag M, Abraldes J, et al.
Gut
. 2022 Jan;
71(9):1856-1866.
PMID: 34992134
Objective: Alcohol-related liver disease (ALD) ranges from never-decompensated ALD (ndALD) to the life-threatening decompensated phenotype, known as alcohol-related hepatitis (AH). A multidimensional study of the clinical, histological and molecular features...
7.
Arab J, Diaz L, Baeza N, Idalsoaga F, Fuentes-Lopez E, Arnold J, et al.
J Hepatol
. 2021 Jun;
75(5):1026-1033.
PMID: 34166722
Background & Aims: Corticosteroids are the only effective therapy for severe alcohol-associated hepatitis (AH), defined by a model for end-stage liver disease (MELD) score >20. However, there are patients who...
8.
Musto J, Eickhoff J, Ventura-Cots M, Abraldes J, Bosques-Padilla F, Verna E, et al.
Liver Transpl
. 2021 Jun;
27(10):1382-1391.
PMID: 34109723
The 10-item Alcohol Use Disorders Identification Test (AUDIT-10) and its shorter form, AUDIT-Consumption (AUDIT-C), are questionnaires used to characterize severity of drinking. We hypothesized that liver injury and short-term outcomes...
9.
Blaya D, Rubio-Tomas T, Rodrigo-Torres D, Lozano J, Coll M, Argemi J, et al.
Hepatol Int
. 2021 May;
15(4):1006-1017.
PMID: 33954832
Objectives: Alcoholic hepatitis (AH) is a severe condition characterized by a marked inflammatory response and high short-term mortality. Endothelial dysfunction (ED) is an early event in vascular and inflammatory disorders....
10.
Parker R, Cabezas J, Altamirano J, Arab J, Ventura-Cots M, Sinha A, et al.
Clin Gastroenterol Hepatol
. 2021 Jan;
20(2):e289-e297.
PMID: 33516950
Background And Aims: Alcoholic hepatitis (AH) is a severe condition with poor short-term prognosis. Specific treatment with corticosteroids slightly improves short-term survival but is associated with infection and is not...